Opko Health (OPK) Gains from Sales and Divestitures (2013 - 2026)
Opko Health (OPK) posted Gains from Sales and Divestitures of $18.04 million for Q2 2026, compared with $72,000 a year earlier.
Powered by 
Analysis
Opko Health (OPK) Gains from Sales and Divestitures (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gains from Sales and Divestitures at Opko Health was $115.79 million, down 7.6% year-over-year; for FY2025, it came in at $101.58 million, down 16.4% from FY2024.
- Annual Gains from Sales and Divestitures shows a five-year compound annual growth rate of 56.9% (FY2020 to FY2025).
- In prior years, Opko Health's Gains from Sales and Divestitures was $121.49 million in FY2024, -$1.32 million in FY2023, $18.56 million in FY2022 (-45.3%) and $33.92 million in FY2021 (+217.6%).
- Quarterly Gains from Sales and Divestitures has run from a low of -$1.85 million in Q1 2023 to a high of $121.49 million in Q3 2024 over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Opko Health | 1.23 Bn | -192.05 Mn | 80.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.04 Mn |
| Mar 31, 2026 | 34,000.00 |
| Sep 30, 2025 | 97.72 Mn |
| Jun 30, 2025 | 72,000.00 |
| Mar 31, 2025 | 3.79 Mn |
| Sep 30, 2024 | 121.49 Mn |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | 123,000.00 |
| Jun 30, 2023 | -230,000.00 |
| Mar 31, 2023 | -1.85 Mn |
| Dec 31, 2022 | 17.75 Mn |
| Sep 30, 2022 | 337,000.00 |
| Jun 30, 2022 | 538,000.00 |
| Mar 31, 2022 | -61,000.00 |
| Dec 31, 2021 | -1.56 Mn |
| Sep 30, 2021 | 32.34 Mn |
| Jun 30, 2021 | 107,000.00 |
| Mar 31, 2021 | 3.04 Mn |
| Dec 31, 2020 | 509,000.00 |
API Access
Opko Health Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=OPK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "OPK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=OPK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();